This was then bound to the Fc component of Cetuximab, a humanized chimeric monoclonal antibody targeting the epidermal growth factor receptor (EGFR), in order to target F98 rat glioma tumor cells overexpressing EGFR [32]. This evidence concerns the gene EGFR and central nervous system cancer.